Fast Five Quiz: Chronic Obstructive Pulmonary Disease Maintenance Therapy

Zab Mosenifar, MD


July 22, 2022

According to 2020 American Thoracic Society clinical practice guidelines, LABA/LAMA combination therapy is recommended for patients with COPD who complain of dyspnea or exercise intolerance. The combination therapy is recommended over LABA or LAMA monotherapy.

ICS are not recommended as monotherapy, according to Agusti and colleagues. The TORCH trial demonstrated that the addition of ICS to a LABA was more beneficial than ICS monotherapy, for example.

Learn more about maintenance therapies for COPD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.